Immune Network

Scope & Guideline

Exploring the Frontiers of Immunity and Disease

Introduction

Explore the comprehensive scope of Immune Network through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Immune Network in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1598-2629
PublisherKOREA ASSOC IMMUNOLOGISTS
Support Open AccessNo
CountrySouth Korea
TypeJournal
Convergefrom 2016 to 2024
AbbreviationIMMUNE NETW / Immune Netw.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKOREA SCIENCE & TECHNOLOGY CENTER, RM 701, 7 GIL 22, TEHERAN-RO, (635-4 YEOKSAM-DONG) GANGMAN-GU, SEOUL 06130, SOUTH KOREA

Aims and Scopes

The journal 'Immune Network' primarily focuses on the intricate mechanisms underlying immune responses, exploring both innate and adaptive immunity across various contexts, including infections, autoimmune diseases, and cancer. It aims to advance the understanding of immunological processes and contribute to the development of innovative therapeutic strategies.
  1. Innate and Adaptive Immunity:
    The journal extensively covers research related to both innate and adaptive immune mechanisms, including the roles of various immune cells such as T cells, B cells, macrophages, and natural killer cells in health and disease.
  2. Immunotherapy and Vaccine Development:
    A significant focus is placed on the development and optimization of immunotherapies and vaccines, addressing how immune responses can be harnessed or modulated to treat diseases such as cancer and infectious diseases.
  3. Autoimmunity and Inflammation:
    Research examining the mechanisms of autoimmune diseases and chronic inflammation is a core area, with studies exploring the roles of cytokines, immune cell interactions, and signaling pathways.
  4. Host-Pathogen Interactions:
    The journal includes studies on host-pathogen interactions, particularly regarding how pathogens evade immune responses, as well as the immune system's mechanisms to combat infections.
  5. Translational Research and Clinical Applications:
    There is a consistent emphasis on translating basic immunological research into clinical applications, including the study of immune responses in various patient populations and the evaluation of new therapeutic strategies.
The 'Immune Network' has been increasingly publishing research on several trending and emerging themes, reflecting the evolving landscape of immunology and its applications. These themes highlight innovative approaches and areas of significant interest within the field.
  1. Microbiome and Immune Interactions:
    Research exploring the relationship between the microbiome and immune responses is gaining traction, emphasizing how gut microbiota can influence systemic immunity and disease outcomes.
  2. Cellular Metabolism in Immunity:
    There is a rising interest in the role of cellular metabolism in shaping immune cell function, particularly how metabolic pathways affect T cell differentiation and macrophage polarization.
  3. Long-COVID and Immune Dysregulation:
    Emerging studies are increasingly focused on the immunological aspects of long-COVID, investigating how SARS-CoV-2 infection can lead to persistent immune dysregulation.
  4. Novel Immunotherapeutic Approaches:
    The exploration of novel immunotherapeutic strategies, including bispecific antibodies and cell therapies, is becoming a prominent focus, reflecting a shift towards more personalized medicine in immunotherapy.
  5. Innate Immunity in Cancer Therapy:
    There is a growing body of research investigating the roles of innate immune components, such as natural killer cells and macrophages, in the context of cancer therapy, indicating a trend towards harnessing innate immunity.

Declining or Waning

In recent years, certain themes within the 'Immune Network' have shown a decline in prominence, reflecting shifts in research focus or changes in scientific priorities. These waning scopes may indicate areas where research is becoming less active or where new methodologies are replacing older ones.
  1. Traditional Vaccine Platforms:
    Research focused on traditional vaccine platforms, such as inactivated or live-attenuated vaccines, appears to be declining as newer mRNA and viral vector technologies gain prominence.
  2. Basic Mechanisms of T Cell Activation:
    While still important, the basic mechanisms of T cell activation have received less attention compared to more complex and context-dependent studies of T cell functions in disease settings.
  3. Cytokine Research in Isolation:
    Studies examining the roles of individual cytokines in isolation are waning, as there is a shift towards understanding the broader networks of cytokine interactions and their implications in immune responses.
  4. Animal Models of Disease:
    There has been a gradual decrease in publications focused solely on animal models of diseases, with a growing preference for studies that incorporate human data or translational approaches.

Similar Journals

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Transforming Research into Clinical Practice
Publisher: OXFORD UNIV PRESSISSN: 0009-9104Frequency: 12 issues/year

Clinical and Experimental Immunology, published by Oxford University Press, is a premier journal that has been a cornerstone in the field of immunology since its inception in 1966. With an ISSN of 0009-9104 and an E-ISSN of 1365-2249, this journal holds a significant position in academic research, currently ranking in the Q2 category for both Immunology and Allergy (2023). Its impactful contributions are reflected in its Scopus rankings, where it stands at Rank #63 out of 233 in Immunology and Allergy, placing it in the 73rd percentile, and Rank #73 out of 236 in Immunology and Microbiology. Researchers, healthcare professionals, and students will find this journal an invaluable resource for cutting-edge studies, reviews, and clinical advancements in the ever-evolving domain of immunology. While the publication does not offer open-access options, it remains a pivotal platform for disseminating knowledge that impacts both clinical practice and experimental research.

INFLAMMATION RESEARCH

Advancing knowledge in the realm of inflammation.
Publisher: SPRINGER BASEL AGISSN: 1023-3830Frequency: 12 issues/year

INFLAMMATION RESEARCH, published by SPRINGER BASEL AG, serves as a pivotal journal in the fields of Immunology and Pharmacology, with notable rankings of Q2 in Immunology and Q1 in Pharmacology as of 2023. With an ISSN of 1023-3830 and an E-ISSN of 1420-908X, this esteemed journal, located in Basel, Switzerland, has been at the forefront of advancing our understanding of inflammatory processes since its inception in 1995. Covering research trends and breakthroughs until 2024, it significantly contributes to both the theoretical frameworks and practical applications within its discipline, boasting a strong Scopus ranking of #40/313 in Pharmacology and #56/236 in Immunology, placing it in the top percentiles for its field. Although it does not offer Open Access options, the journal remains an invaluable resource for researchers, professionals, and students committed to unraveling the complexities of inflammation and its implications in health and disease.

Mucosal Immunology

Innovating Insights into Immune Interactions
Publisher: ELSEVIER SCIENCE INCISSN: 1933-0219Frequency: 6 issues/year

Mucosal Immunology, published by Elsevier Science Inc, is a leading journal dedicated to advancing the field of immunology with a particular focus on mucosal immunity. Since its inception in 2008, the journal has established itself as a premier source of cutting-edge research, evidenced by its impressive Q1 ranking in both Immunology and Allergy for 2023, and its notable positions within the top ranks of Scopus (Rank #21/233 in Immunology and Allergy and Rank #24/236 in Immunology and Microbiology). The journal serves as a vital resource for researchers, professionals, and students aiming to explore the complexities of mucosal immune responses and their implications in health and disease. While it operates under a subscription model, Mucosal Immunology is committed to disseminating quality research globally and enhancing collaborative efforts within the scientific community. Explore the latest findings and connect with influential scholarship in this rapidly evolving field.

Immunotherapy Advances

Transforming patient care through innovative immunotherapeutic insights.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Immunotherapy Advances, published by Oxford University Press, stands at the forefront of the rapidly evolving field of immunology and microbe interactions, focusing specifically on novel immunotherapeutic strategies and their clinical applications. Established in 2021, this peer-reviewed journal aims to disseminate high-quality research that contributes to the understanding and advancement of immunotherapeutic techniques, potentially transforming patient care in immunology. With a current Scopus rank of #140 out of 236 in the realm of Immunology, placing it in the 40th percentile, Immunotherapy Advances is positioned to be an integral resource for researchers, healthcare professionals, and students eager to stay updated with groundbreaking findings and methodologies. The journal is dedicated to fostering innovative discussions and collaborations, ensuring open access to vital research that influences treatment paradigms globally.

Immunological Medicine

Fostering Collaboration in Immunological Breakthroughs
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 4 issues/year

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

IMMUNOLOGY

Pioneering Discoveries in Immunology Since 1958
Publisher: WILEYISSN: 0019-2805Frequency: 12 issues/year

IMMUNOLOGY is a premier journal published by Wiley that has been at the forefront of the field since its inception in 1958. With an impressive impact factor and classified in the Q1 quartile for both Immunology and Allergy as of 2023, this journal is highly regarded among researchers and professionals alike. It ranks 36th out of 233 in the Medicine/Immunology and Allergy category, and 40th out of 236 in the Immunology and Microbiology segment on Scopus, placing it firmly within the top percentile of its field. The journal is dedicated to publishing high-quality research that advances our understanding of immunological processes, bridging basic science with clinical applications. Although it does not operate under an open-access model, it offers conventional access options that remain integral to the dissemination of vital immunological research. With its broad scope and commitment to scholarly excellence, IMMUNOLOGY continues to serve as an essential resource for those seeking the latest advancements in immunology, fostering innovation and collaboration among scientists globally.

NATURE IMMUNOLOGY

Transforming research into real-world applications in immunology.
Publisher: NATURE PORTFOLIOISSN: 1529-2908Frequency: 12 issues/year

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

IMMUNOLOGY AND CELL BIOLOGY

Cutting-edge Insights into Immune Responses and Cellular Dynamics
Publisher: WILEYISSN: 0818-9641Frequency: 10 issues/year

IMUNOLOGY AND CELL BIOLOGY, published by Wiley, serves as a prominent platform for disseminating cutting-edge research in the fields of immunology and cell biology. With an ISSN of 0818-9641 and an E-ISSN of 1440-1711, this journal has established itself since its inception in 1987, demonstrating a commitment to advancing knowledge in its disciplines through high-quality articles. Renowned for its rigorous peer-review process, it holds a Q2 quartile ranking in both immunology and cell biology categories as of 2023, showing its competitive stature in these fields. IMUNOLOGY AND CELL BIOLOGY is indexed among the elite journals worldwide, with impressive Scopus rankings, including a rank of #75/233 in Immunology and Allergy. The journal’s comprehensive scope ensures that it caters to an audience of researchers, professionals, and students who are dedicated to exploring the intricate mechanisms of immune responses and cellular interactions. Although it does not operate under an open access model, its subscription-based content remains invaluable for those seeking to broaden their understanding of immunology and cell biology. By providing a forum for significant scientific dialogue, IMUNOLOGY AND CELL BIOLOGY continues to shape the future of research in these vital areas.

INTERNATIONAL REVIEWS OF IMMUNOLOGY

Fostering Breakthroughs in Immunological Understanding
Publisher: TAYLOR & FRANCIS INCISSN: 0883-0185Frequency: 6 issues/year

INTERNATIONAL REVIEWS OF IMMUNOLOGY, published by Taylor & Francis Inc, is a leading academic journal that has been a cornerstone of immunological research since its inception in 1986. With an impressive impact factor and ranked in the top quartiles of its field (Q2 in both Immunology and Allergy), this journal offers a critical platform for the dissemination of influential findings and advancements within immunology. Spanning a diverse array of topics, from basic immune mechanisms to clinical applications, it aims to support the global scientific community in enhancing immunological understanding and therapeutic interventions. Researchers and professionals alike benefit from insights provided by renowned contributors, ensuring that the journal remains relevant in a rapidly evolving field. Directly accessible through subscription or institutional access, INTERNATIONAL REVIEWS OF IMMUNOLOGY is committed to fostering collaboration and innovation, making it an essential resource for anyone involved in immunological research and practice.

JOURNAL OF EXPERIMENTAL MEDICINE

Pioneering Discoveries in Experimental Medicine
Publisher: ROCKEFELLER UNIV PRESSISSN: 0022-1007Frequency: 12 issues/year

JOURNAL OF EXPERIMENTAL MEDICINE, published by Rockefeller University Press, is a renowned peer-reviewed journal dedicated to advancing the field of experimental medicine since its inception in 1896. With an impressive impact factor and categorized in the Q1 quartile for Immunology, Immunology and Allergy, and Miscellaneous Medicine, this journal stands at the forefront of medical research and innovation. It provides a prestigious platform for scholars and practitioners to disseminate groundbreaking findings that drive the understanding of disease mechanisms and therapeutic strategies. While the journal is not open access, it maintains high visibility and engagement within the scientific community, fostering collaboration among researchers, professionals, and students alike. The journal's consistent ranking in the top percentiles of Scopus illustrates its significant impact and commitment to excellence in medical research.